Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery

Singapore Medical Journal

Volumn 49, Issue 11, 2008, Pages 904-911

  Kuru, Bekir ^a   Camlibel, M ^b   Dinc, S ^b   Gulcelik, M A ^b   Gonullu, D ^c   Alagol, H ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Apex axillary invasion; Breast cancer; Oestrogen receptor; Skeletal metastasis; Stage IIIC breast cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; TREATMENT OUTCOME; VISCERAL METASTASIS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RECEPTORS, ESTROGEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 57149103134     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. James JJ, Evans AJ, Pinder SE, et al. Bone metastases from breast carcinoma: histopathological-radiological correlations and prognostic features. Br J Cancer 2003; 89:660-65.
2. Moore MP, Kinne DW. Pattern of recurrence in breast cancer. In: Bland KI, Copeland EM, eds. The Breast. 2nd ed. Philadelphia: WB Saunders; 1998: 395-99.
3. Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 2001; 91:17-24.
4. Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 1998; 77:336-40.
5. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 2000; 59:271-8.
6. Lipton A. Towards new horizons: the future of bisphosphonate therapy. Oncologist 2004; 9 Suppl 4:38-47.
7. Green JR. Bisphosphonates: Preclinical review. Oncologist 2004; 9 Suppl 4:3-13.
8. Powles T, Paterson S, Kanis, JA et al. Randomized, placebo controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 2002; 20:3219-24.
9. Koizumi M, Yoshimoto M, Kasumi F, Ogata E. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol 2003; 14:1234-40.
10. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: Relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987; 5:55-61.
11. Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ. Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 1992; 21:173-80.
12. Kuru B, Bozgül M. The impact of removed axillary lymph nodes in staging of node positive breast carcinoma. Int J Radiat Oncol Biol Biophys 2006; 66:1328-34.
13. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 2002; 20:3628-36.
14. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 1991; 19:403-10.
15. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. 3rd ed. Pacific Grove: Duxbury Press, 1998.
16. Hosmer DW, Lemeshow S. Applied Survival Analysis. Regression Modelling of Time to Event Data. New York: Wiley-Interscience, 1999.
17. Chang J, Clark GM, Allred DC, et al. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 2003; 97:545-53.
18. Insa A, Lluch A, Prosper F, et al. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999; 56:67-78.
19. Jimeno A, Amador ML, González-Cortijo L, et al. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma. Cancer 2004; 100:1833-42.
20. Porter GJ, Evans AJ, Pinder SE, et al. Patterns of metastatic breast carcinoma. Influence of tumor histological grade. Clin Radiol 2004; 59:1094-98.
21. Howell A, Barnes DM, Harland RN, et al. Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet 1984; 1:588-91.
22. Newman LA, Kuerer HM, Fornage B, et al. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 2001; 181:313-8.
23. Kuru B, Camlibel M, Dinc S, Gulcelik MA, Alagol H. Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy. Eur J Surg Oncol 2003; 29:839-44.
24. Kuru B, Camlibel M, Dinc S, Gulcelik MA, Alagol H. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients. World J Surg 2004; 28:236-41.
25. Henderson IC, Garber JE, Breitmeyer JB, Hayes DF, Harris JR. Comprehensive management of disseminated breast cancer. Cancer 1990; 66(6 Suppl):1439-48.